Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Xin Peng; Shaolu Zhang; Wenhui Jiao; Zhenxing Zhong; Yuqi Yang; Francois X Claret; Moshe Elkabets; Feng Wang; Ran Wang; Yuxu Zhong; Zhe-Sheng Chen; Dexin Kong

doi:10.1186/s13046-021-02218-9

Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

J Exp Clin Cancer Res. 2021 Dec 20;40(1):396. doi: 10.1186/s13046-021-02218-9.

Authors

Xin Peng^#^{1

2

3}, Shaolu Zhang^#^{1

2

4}, Wenhui Jiao^{1

2}, Zhenxing Zhong^{1

2}, Yuqi Yang⁵, Francois X Claret³, Moshe Elkabets⁶, Feng Wang⁷, Ran Wang^{8

9}, Yuxu Zhong¹⁰, Zhe-Sheng Chen¹¹, Dexin Kong^{12

13

14}

Affiliations

¹ Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China.
² Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin, 300070, China.
³ Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
⁴ State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
⁵ Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, NY, 11439, USA.
⁶ The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
⁷ Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
⁸ Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. wangran@tmu.edu.cn.
⁹ Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin, 300070, China. wangran@tmu.edu.cn.
¹⁰ State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. yuxuzhong2008@aliyun.com.
¹¹ Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, NY, 11439, USA. chenz@stjohns.edu.
¹² Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. kongdexin@tmu.edu.cn.
¹³ Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin, 300070, China. kongdexin@tmu.edu.cn.
¹⁴ School of Medicine, Tianjin Tianshi College, Tianyuan University, Tianjin, 301700, China. kongdexin@tmu.edu.cn.

^# Contributed equally.

No abstract available

Publication types

Published Erratum